Early Alzheimer's Disease Clinical Research Study

TRAILRUNNER-ALZ 3 is a clinical research study from Eli Lilly and Company. It is testing if an investigational medicine may help treat people who may have early Alzheimer’s disease or may be at risk for developing symptoms of Alzheimer’s disease. An investigational medicine is a medicine that is being studied to treat a certain health condition.

Be part of a study that could shape the future of Memory Care!

Get started now

Between 50 to 80 years old
Have no to mild issues with your memory
Willing to obtain a blood test as part of
the study that checks whether you have an
abnormal protein associated with Alzheimer’s
disease
Have a reliable study partner (spouse, partner, family member, friend, or someone else whose job is to help you)

Who is it for?

Access to potential new treatments before they are widely available
Free medical care and health monitoring during the study
Contribute to advancing medical research and helping future generations
If you qualify, you may be compensated for your time and travel

Benefits of participanting

How did you find us?
Are you between 50 and 80 years old
Have no to mild issues with your memory
Are willing to obtain a blood test as part of the study that checks whether you have an abnormal protein associated with Alzheimer's disease,
A study partner is a person who knows you well and would notice any changes in your memory, mood, and behavior. This could be your spouse, partner, friend, family member, or someone whose job it is to help you.

Don’t see what you’re looking for?

View other studies